Ethyl 4-methyl-2-phenyl-1,3-thiazole-5-carboxylate (CAS 53799-71-8; molecular formula C13H13NO2S; molar mass 247.31 g·mol−1) constitutes a functionalized thiazole ester deployed primarily as a late-stage intermediate in pharmaceutical process chemistry and agrochemical lead optimization. The heterocyclic core integrates a phenyl substituent at the 2-position and a methyl group at the 4-position, with the ethyl carboxylate moiety at the 5-position conferring differential reactivity toward nucleophilic acyl substitution compared to the corresponding methyl ester or free acid. Commercial material is typically supplied as a pale yellow to off-white crystalline powder with a melting point range of 58–62 °C (determined by differential scanning calorimetry at a heating rate of 10 K·min−1 under nitrogen) and an assay specification of ≥98.0% (HPLC, λ = 254 nm, area normalization). Routine quality control parameters additionally include loss on drying ≤0.5% (vacuum oven, 50 °C, 4 h), residue on ignition ≤0.1%, and heavy metals ≤20 ppm (Method II, USP <231>).
What Distinguishes This Ester from Other 2-Phenylthiazole Derivatives?
Substitution pattern dictates the compound’s behavior in metal-catalyzed cross-coupling sequences. The ethyl ester group at C-5 participates in amidation with primary amines under aminolysis conditions (anhydrous toluene, 80–110 °C, 12–24 h) without requiring coupling agents, whereas the corresponding methyl 4-methyl-2-phenyl-1,3-thiazole-5-carboxylate (CAS 53799-70-7, m.p. 96–98 °C) exhibits slower kinetics due to steric and electronic differences in the alkoxide leaving group. In palladium-mediated direct arylation at the 4-methyl position, the ethyl ester remains intact under catalytic conditions (Pd(OAc)2, PCy3, K2CO3, DMAc, 120 °C) where the free carboxylic acid would undergo in situ decarboxylation, limiting scope. These reactivity demarcations are critical when planning convergent synthetic routes in structure–activity relationship campaigns for kinase inhibitors based on thiazole pharmacophores.
From a supply-chain perspective, bulk shipments of the compound are regularly accompanied by a certificate of analysis citing retention time consistency against a qualified reference standard (EP reference standard or equivalent) and residual solvent levels compliant with ICH Q3C (R8) Option 2 limits. Vials or amber glass bottles with polypropylene closures are standard primary packaging; double-layered polyethylene liners inside fibreboard drums serve multi-kilogram orders. Incompatibility with strong bases, acid chlorides, and oxidizing agents must be noted on the safety data sheet in accordance with GHS Revision 9 classification.
A distinct advantage of the ethyl ester in early-phase development is its chromatographic behavior on reversed-phase C18 columns (mobile phase acetonitrile/water 70:30 v/v, 0.1% trifluoroacetic acid, typical retention factor k′ ≈ 4.2), which separates it clearly from the corresponding alcohol, acid, and dimeric by-products. This facilitates purity verification in laboratories operating under ISO/IEC 17025:2017 accredited quality management systems, where method reproducibility across Agilent 1260 Infinity II and Waters Alliance e2695 HPLC platforms has been benchmarked.
When 5-Carboxylate Esters Replace Carboxylic Acids in Amide Coupling
In heterocyclic drug intermediate synthesis, direct aminolysis of preformed esters bypasses the need for carboxylic acid activation, reducing the number of unit operations and circumventing racemization in chrial adjacent centers. Ethyl 4-methyl-2-phenyl-1,3-thiazole-5-carboxylate reacts with substituted benzylamines in the presence of 1.2 equivalents of trimethylaluminum (toluene, 0 °C to reflux) to generate the corresponding N-benzyl amides in yields 72–89%, as documented in process development reports for 2-aminothiazole-based CRF1 receptor antagonists. The methyl ester counterpart typically requires higher temperatures (≥130 °C in N-methylpyrrolidone) to reach comparable conversion, and thus poses greater thermal hazard potential during scale-up in batch reactors equipped with external steam jackets.
Operational boundary: Reactions involving primary aliphatic amines and the ethyl ester are susceptible to moisture-induced ester hydrolysis; Karl Fischer titration of the solvent must read ≤200 ppm H2O before charging. Failure to control water content routinely gives rise to 5–12% of the free acid impurity, which partitions into the aqueous workup and depresses yield. Furthermore, exposure of the solid intermediate to relative humidity exceeding 60% for periods longer than 24 h at 25 °C causes observable caking and a 2–3% decrease in HPLC purity, mandating resealed foil-lined containers after each use.
Applications in Heterocyclic Scaffold Assembly
Beyond amide formation, the thiazole ester participates in cyclocondensation chemistry with hydrazine hydrate to afford 5-carbohydrazide derivatives, which are routinely converted into oxadiazole and triazole annulated systems in medicinal chemistry programs targeting bacterial enoyl-ACP reductase (FabI). In a published procedure compliant with the ACS Green Chemistry Institute’s Pharmaceutical Roundtable solvent selection guide, ethyl 4-methyl-2-phenyl-1,3-thiazole-5-carboxylate undergoes hydrazinolysis in absolute ethanol (reflux, 6 h) to yield the hydrazide in >95% conversion as monitored by inline ReactIR 15 with a DiComp probe. The resulting hydrazide is then immediately condensed with carbon disulfide under basic conditions to build a 1,3,4-thiadiazole-2-thiol motif, a privileged fragment in antimycobacterial screening.
In agrochemical synthesis, the same intermediate has been elaborated into 5-pyrazole-substituted thiazoles with structural similarity to fluxapyroxad, a succinate dehydrogenase inhibitor (SDHI) fungicide. Here the ethyl ester is engaged in a Claisen condensation with acetophenone enolates, generating a β-keto ester that is trapped with methylhydrazine. The regioselectivity of pyrazole ring closure is influenced by the steric bulk of the 4-methyl group; 85:15 ratios of the 5-pyrazolyl to the 3-pyrazolyl isomer are typical when the reaction is run in THF at −20 °C with LiHMDS as base. Published data for this specific configuration with phenyl-substituted analogues confirm the importance of the ethyl ester in minimizing transesterification side products that plague methyl esters under these strongly basic conditions.
| Ester | Amine (1.5 equiv) | Conversion at 6 h (%) | Observed Impurity (Area%) | Reference Method |
|---|---|---|---|---|
| Ethyl 4-methyl-2-phenyl-1,3-thiazole-5-carboxylate | Benzylamine | 94.2 | Free acid 2.1 | HPLC UV 254 nm, EP system suitability |
| Methyl 4-methyl-2-phenyl-1,3-thiazole-5-carboxylate | Benzylamine | 78.7 | Free acid 3.8 + methyl ester hydrolysis | Same |
| Ethyl 4-chloro-2-phenyl-1,3-thiazole-5-carboxylate | Benzylamine | 96.5 | Chloro-displacement product 8.3 | GC-FID (DB-5 column, 30 m) |
The chloro analogue above highlights the overriding effect of the C-4 substituent: nucleophilic displacement of the chlorine atom occurs competitively, rendering the 4-chloro compound unsuitable for straightforward aminolysis without protecting-group strategies. Thus, the 4-methyl variant is preferred when late-stage diversification demands preservation of the thiazole ring substituent integrity.
Thermal and Photochemical Stability Under Processing Conditions
Differential scanning calorimetry (DSC) on the neat solid at a scan rate of 10 °C·min−1 (ASTM E537-20) shows a single endothermic melt event at 60.3 °C (onset) without detectable exothermic decomposition below 250 °C. Accelerating rate calorimetry (ARC) data in a titanium bomb (Phi-Tec II, Φ-factor 1.2) indicates an onset of self-sustaining decomposition at 295 °C with a maximum self-heat rate of 3.2 °C·min−1, placing it within the “low thermal risk” category according to the Stoessel criticality index. These characteristics allow standard drying procedures at 40–50 °C under reduced pressure (≤50 mbar) in agitated filter-dryers (e.g., Rosenmund Guedu type) without measurable degradation over 16-hour cycles.
Photolytic degradation studies conducted in accordance with ICH Q1B (Option 2: cool white fluorescent and near-UV lamps) demonstrate that the solid remains within 0.3% total impurities after exposure to 1.2 million lux·h visible light and 200 W·h·m−2 UV-A. Solutions in acetonitrile or methanol, however, show a 3–5% increase in a photoproduct identified by LC-MS as the decarboxylated 4-methyl-2-phenylthiazole, recommending storage of stock solutions in amber vials and use within 24 h when protected from light.
Stainless steel 316L and Hastelloy C-276 are documented as materials of construction compatible with process streams containing the ester in toluene or tetrahydrofuran at concentrations up to 20 wt%. Batch records from pilot-plant campaigns note that polytetrafluoroethylene (PTFE) gaskets in lobe pumps (e.g., Alfa Laval OptiLobe 50) show no swelling after 200 hours of cumulative contact, while ethylene propylene diene monomer (EPDM) seals experience 8% increase in mass, necessitating scheduled replacement every three production batches.
How Does the 4-Methyl Substituent Influence Pharmacopoeial Compliance?
For pharmaceutical intermediates destined for filings under a US FDA Drug Master File, residual solvent analysis must demonstrate compliance with USP <467> and Ph. Eur. 2.4.24 methods for Class 2 and Class 3 solvents. Typical production routes for ethyl 4-methyl-2-phenyl-1,3-thiazole-5-carboxylate employ acetonitrile or ethyl acetate as reaction solvents, both Class 3 with low toxic potential, and toluene (Class 2) in the final recrystallization. A validated headspace GC-FID method (Agilent 7697A/7890B, DB-624 column 30 m × 0.32 mm × 1.8 µm) quantifies residual toluene at ≤890 ppm and acetonitrile at ≤410 ppm, comfortably within the permissible daily exposure limits defined in ICH Q3C(R8). For comparison, the 4-ethyl homologue consistently retains higher amounts of toluene (≥1200 ppm) under identical recrystallization conditions, attributed to a more compact crystal lattice in the 4-methyl derivative that expels solvent more efficiently during polymorphic transition to Form I (monoclinic P21/c).
Regarding endotoxin control for parenteral-grade starting materials, water-insoluble intermediates such as this ester are not required to meet BET specifications; however, end users performing conversion to a water-soluble amide hydrochloride often request a bioburden limit of ≤100 CFU/g and absence of Pseudomonas aeruginosa by membrane filtration (ISO 11731:2017). Contract manufacturing organizations supply the compound with these optional micro limits upon request, accompanied by an irradiation certificate if gamma-sterilized (25 kGy target dose, dosimetric release per ISO 11137-2).
| Parameter | Specification Limit | Analytical Method / Standard |
|---|---|---|
| Appearance | Off-white crystalline powder | Visual, Ph. Eur. 2.2.1 |
| Identification | IR spectrum concordant, retention time matches reference | FT-IR (ATR), HPLC-UV |
| Assay (anhydrous basis) | 98.0–102.0% | HPLC, EP 2.2.29 |
| Water content | ≤0.5% | Karl Fischer, Ph. Eur. 2.5.12 |
| Residue on ignition | ≤0.1% | Ph. Eur. 2.4.14 |
| Heavy metals | ≤20 ppm | USP <231>, Method II |
| Residual toluene | ≤890 ppm | GC-HS, USP <467> |
| Melting point | 58–62 °C | DSC / open capillary |
Coordination with excipient compatibility studies (forced degradation binary mixtures at 40 °C/75% RH for 4 weeks) has shown that the ester is inert toward common tablet fillers such as microcrystalline cellulose and pregelatinized starch, but reacts slowly with dicalcium phosphate dihydrate (DCPD) in the presence of moisture to form the calcium salt of the free acid, lowering the purity by 1.5–3%. This finding precludes formulation strategies that rely on DCPD as a direct-compression excipient for fixed-dose combinations where the intermediate is present as a processing aid.
Ultimately, the selection of ethyl 4-methyl-2-phenyl-1,3-thiazole-5-carboxylate over alternative thiazole carboxylates in any synthetic route is governed by a narrow processing window of hydrolysis resistance and crystallinity, validated on production-scale isolations in centrifuge-dried (Heinkel H 800 P) and conical dryer (BOLZ-SUMMIX) configurations. The body of analytical and stability data described here serves to establish operational and specification benchmarks without extrapolation beyond the documented substance-specific boundaries.